Zusammenfassung
Die exokrine und endokrine Funktion des Pankreas wird über Peptide der Darmschleimhaut sowie über nervale Mechanismen reguliert. Der nach Nahrungsaufnahme jeweils unterschiedliche Darminhalt reguliert dabei die spezifischen Antworten der Organe. Es soll in diesem Kapitel die funktionelle Verknüpfung der exokrinen (enteroazinäre bzw. exokrine Achse) sowie der endokrinen Funktion (enteroinsuläre bzw. endokrine Achse) des Pankreas mit dem Darm beschrieben werden.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Literatur
Angelini G, Cavallinin G, Bovo G, Castagnini A, Lavarmi E, Merigo F et al. (1988) Pancreatic function in chronic inflammatory bowel disease. Int J Pancreatol 3:185–193
Adler G, Nelson DK, Katschinski M, Beglinger C (1995) Neurohormonal control of human pancreatic exocrine secretion. Pancreas 10:1–13
Bayliss WM, Starling EH (1902) The mechanism of pancreatic secretion. J Physiol (Lond) 28:325–353
Bell GI, Sauterre RF, Mullenbach GT (1983) Hamster pre-proglucagon contains the sequence of glucagon and two related peptides. Nature 302:716–718
Brown JC, Dryburgh JR (1971) A gastric inhibitory polypeptide II. The complete amino acid sequence. Can J Biochem 49:867–872
Costa E, Guidotti A (1991) Diazepam binding inhibitor (DBI) A peptide with multiple biological actions. Life Sci 49:325–344
Creutzfeldt W (1979) The incretin concept today. Diabetologia 16:75–85
Creutzfeldt W, Ebert R (1985) New developments in the incretin concept. Diabetologia 28:565–573
DiMagno EP, Summerskill WH (1972) Impaired cholecysto-kinin-pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue. Gastroenterology 63:25–32
Drucker DJ (1998) Glucagon-like peptides. Diabetes 47:159–169
Fehmann HC, Göke R, Göke B (1995) Cell and molecular biology of the incretin hormones glucagon-like peptide-I and glucose dependent insulin-releasing polypeptide. Endocr Rev 16:390–410
Go VLW, Hoffman AF, Summerskill WHJ (1970) Pancreozymin bioassay in man based on pancreatic enzyme secretion: Potency of specific amino acids and other digestive products. J Clin Invest 49:1558–1564
Göke B, Fehmann HC, Schirra J, Hareter A, Göke R (1997) Das Darmhormon Glucagon-like peptide-1 (GLP-1): aus dem Experiment in die Klinik. Z Gastroenterol 35:285–294
Gutniak M, Orskov C, Holst JJ (1992) Antidiabetogenic effect of glucagon-like peptide 1(7-37) amide in normal subjects and patients with diabetes mellitus. New Engl J Med 326:1310–1322
Heikus B, Niemelä S, Lehtola J, Karttunen T, Lähde S (1996) Pancreatic duct abnormalities and pancreatic function in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 31:517–523
Herzig KH (1998) CCK-releasing peptides. Regul Peptides 73:89–94
Herzig KH, Fölsch UR (1995) Feedback-Regulation. In: Erkrankungen des exkretorischen Pankreas. In: Mössner J, Adler G, Fölsch UR, Singer MV (Hrsg) Gustav Fischer, Jena, S 83–91
Herzig KH, Schön I, Tatemoto K, Ohe Y, Fölsch UR, Owyang C (1996) Diazepam binding inhibitor is a potent cholecystokinin releasing peptide in the intestine. Proc Natl Acad Sci, USA 93:7927–7932
Herzig KH, Wilgus C, Schön I, Tatemoto K, Fölsch UR (1998) Regulation of the action of the novel CCK releasing peptide diazepam binding inhibitor by inhibitory hormones and taurocholate. Regul Peptides 74:193–198
Hopman WPM, Rosenbusch G, Hectors MPC, Jansen JBMJ (1995) Effect of predigested fat on intestinal stimulation of plasma cholecystokinin and gall bladder motility in coeliac disease. Gut 36:17–21
Hussain MA (1998) A biological function for glucagon-like peptide-2. Eur J Endocrinol 139:265–267
Ihse I, Lilja P, Lundquist I (1977) Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion 15:303–308
Ivy AC, Oldberg E (1928) A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 86:599–613
Iwai K, Fukuoka S, Fushiki T, Tsujikawa M, Hirose M, Tsunasawa S et al. (1987) Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from rat pancreatic juice. J Biol Chem 262:8956–8959
Jain NK, Boivin M, Zinsmeister AR, DiMagno EP (1991) The ileum and carbohydrate-mediated feedback regulation of postprandial pancreaticobiliary secretion in normal humans. Pancreas 6:495–505
Johansson O, Hilliges M, Östenson CG, Sandberg E, Efendic S, Mutt V (1991) Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreas. Cell Tissue Res 263:395–398
LaBarre J, Still EU (1930) Studies on the physiology of secretin: III Further studies in the effects on secretin on the blood sugar. Am J Physiol 91:649–653
Lauritsen KB, Moody AJ, Christensen KC, Jensen SL (1981) Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man. Scand J Gastroenterol 16:417–423
Layer P, Peschel S, Schlesinger T, Goebell H (1990) Human pancreatic secretion and intestinal motility: effects of ileal nutrient perfusion. Am J Physiol 258: G196–G201
Moore B, Edie ES, Abram JH (1906) On the treatment of diabetes mellitus by acid extract of duodenal mucous membrane. Biochem 11:28–38
Owyang C, Green L, Rader D (1983) Colonic inhibition of pancreatic and biliary secretion. Gastroenterology 84:470–475
Owyang C, Louie DS, Tatum D (1986) Feedback regulation of pancreatic enzyme secretion. Suppression of cholecystokinin release by trypsin. J Clin Invest 77:2042–2047
Owyang C, May D, Louie DS (1986) Trypsin suppression of pancreatic enzyme suppression. Differential effect on cholecystokinin release and the enteropancreatic reflex. Gastroenterology 91:637–643
Sarson DL, Wood SM, Holder D, Bloom SR (1982) The effect of glucose-dependent insulinotropic polypeptide infused at physiological concentrations on the release of insulin in man. Diabetologica 22:33–36
Schmidt WE, Creutzfeldt W, Schleser A, Roy Choudhury A, Nustede R, Höcker M et al. (1991) Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Am J Physiol 260: G197–G206
Spannagel AW, Green GM, Guan D, Liddle RA, Faull K, Reeve Jr, JR (1996) Purification and characterization of a luminal cholecystokinin-releasing factor from rat intestinal secretion. Proc Natl Acad Sci USA 93:4415–4420
Tarasova N, Spannagel AW, Green GM, Gomez G, Reed JT, Thompson JC et al. (1997) Distribution and localization of a novel cholecystokinin-releasing factor in the rat intestinal tract. Endocrinology 138:5550–5554
Tromm A, Höltmann B, Hüppe D, Kuntz HD, Schwengler U, May B (1991) Hyperamylasämie, Hyperlipasämie und akute Pankreatitiden bei chronisch entzündlichen Darmerkrankungen. Leber Magen Darm 1:15–22
Yasui A, Nimura Y, Hayakawa S, Shionoya S (1988) Feedback regulation of basal pancreatic secretion in humans. Pancreas 3:681–687
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Herzig, K.H., Otte, J.M., Fölsch, U.R. (1999). Intestinaltrakt und Pankreas. In: Caspary, W.F., Stein, J. (eds) Darmkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59960-6_58
Download citation
DOI: https://doi.org/10.1007/978-3-642-59960-6_58
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64197-8
Online ISBN: 978-3-642-59960-6
eBook Packages: Springer Book Archive